SunTrust Banks reissued their hold rating on shares of Teladoc Health (NYSE:TDOC) in a report published on Monday, AnalystRatings.com reports. They currently have a $80.00 price objective on the health services provider’s stock.
TDOC has been the topic of a number of other research reports. Zacks Investment Research cut shares of Teladoc Health from a buy rating to a hold rating and set a $89.00 target price on the stock. in a research note on Wednesday, November 27th. Stifel Nicolaus assumed coverage on shares of Teladoc Health in a research note on Monday, November 25th. They issued a hold rating and a $83.00 price objective for the company. ValuEngine upgraded shares of Teladoc Health from a buy rating to a strong-buy rating in a research report on Tuesday, October 22nd. JPMorgan Chase & Co. lifted their target price on shares of Teladoc Health from $82.00 to $83.00 and gave the company an overweight rating in a research note on Thursday, September 19th. Finally, Deutsche Bank started coverage on shares of Teladoc Health in a report on Thursday, September 12th. They issued a buy rating and a $76.00 target price for the company. Four research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of Buy and an average target price of $81.73.
NYSE TDOC opened at $78.44 on Monday. The stock’s 50-day moving average price is $76.62 and its 200-day moving average price is $67.18. The company has a quick ratio of 6.55, a current ratio of 6.55 and a debt-to-equity ratio of 0.44. Teladoc Health has a 52 week low of $42.08 and a 52 week high of $86.30. The company has a market capitalization of $6.06 billion, a P/E ratio of -54.47 and a beta of 1.40.
In related news, insider Adam C. Vandervoort sold 50,955 shares of the business’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $75.00, for a total value of $3,821,625.00. Following the sale, the insider now directly owns 9,769 shares in the company, valued at $732,675. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Lewis Levy sold 675 shares of the stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $60.00, for a total value of $40,500.00. Following the transaction, the insider now directly owns 4,805 shares of the company’s stock, valued at $288,300. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 76,582 shares of company stock valued at $5,614,983. 3.14% of the stock is owned by company insiders.
A number of large investors have recently added to or reduced their stakes in the business. Westside Investment Management Inc. bought a new position in shares of Teladoc Health during the 2nd quarter valued at approximately $26,000. CNB Bank grew its position in Teladoc Health by 100.0% in the third quarter. CNB Bank now owns 400 shares of the health services provider’s stock worth $27,000 after acquiring an additional 200 shares in the last quarter. Capital Investment Advisory Services LLC grew its position in Teladoc Health by 800.0% in the third quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock worth $30,000 after acquiring an additional 400 shares in the last quarter. Tradewinds Capital Management LLC increased its stake in Teladoc Health by 186.0% during the second quarter. Tradewinds Capital Management LLC now owns 615 shares of the health services provider’s stock worth $41,000 after acquiring an additional 400 shares during the last quarter. Finally, Quadrant Capital Group LLC raised its position in Teladoc Health by 32.4% during the third quarter. Quadrant Capital Group LLC now owns 621 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 152 shares during the period.
About Teladoc Health
Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Further Reading: Google Finance Portfolio
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.